Antitumor activities of kushen: Literature review

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Sun, Mingyu ^a,b   Cao, Hongyan ^a   Sun, Lin ^c   Dong, Shu ^a   Bian, Yanqin ^a   Han, Jun ^d   Zhang, Lijun ^a   Ren, Shuang ^a   Hu, Yiyang ^a,b   Liu, Chenghai ^a,b   Xu, Lieming ^a,b   Liu, Ping ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b E institute of Shanghai Municipal Education Commission   (China)

^c LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FENTANYL; FLAVONOID; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; INDOMETACIN; IRINOTECAN; MATRINE; MITOMYCIN; OXALIPLATIN; OXYMATRINE; PACLITAXEL; PIRARUBICIN; SOPHORA FLAVESCENS EXTRACT; TRAMADOL; UFT; VINBLASTINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; BONE MARROW TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER STEM CELL; CHEMICAL STRUCTURE; COLON CANCER; COLORECTAL CANCER; CONSTIPATION; ESOPHAGUS CANCER; GASTROINTESTINAL TUMOR; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; KUSHEN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG CANCER; LUNG TUMOR; MALIGNANT ASCITES; NAUSEA; NONHUMAN; OVARY CANCER; PLANT ROOT; PRIORITY JOURNAL; REVIEW; SOPHORA FLAVESCENS; STOMACH CANCER; UTERINE CERVIX CANCER;

EID: 84866149262     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/373219     Document Type: Review

References (85)

1. Sun F. G., Sun X. Y., Sophora flavescens. Shen Nong Ben Cao Jing 1999 1st Scientific and Technical Documents Publishing House 59
2. Sophora flavescens. Zhonghua Bencao 1999 4 1st Shanghai Science and Technology Press 634 643
3. Wang Y., Research progress on chemical constituents, preparative separation and quality of Sophora flavescens. Chinese Traditional Patent Medicine 1997 19 39 41
4. Sun M., Han J., Duan J., Cui Y., Wang T., Zhang W., Liu W., Hong J., Yao M., Xiong S., Yan X., Novel antitumor activities of Kushen flavonoids in vitro and in vivo. Phytotherapy Research 2007 21 3 269 277 2-s2.0-33947686806 10.1002/ptr.2066 (Pubitemid 46486572)
5. Cheng H., Xia B., Zhang L., Zhou F., Zhang Y. X., Ye M., Hu Z. G., Li J., Li J., Wang Z. L., Li C., Guo Q. S., Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Pharmacological Research 2006 53 3 202 208 2-s2.0-32644470998 10.1016/j.phrs.2005.11.001 (Pubitemid 43247532)
6. Zhang M. J., Huang J., Recent research progress of anti-tumor mechnism matrine. China Journal of Chinese Materia Medica 2004 29 2 117 118 2-s2.0-24344438685 (Pubitemid 41246813)
7. Xu G. L., Yao L., Rao S. Y., Gong Z. N., Zhang S. Q., Yu S. Q., Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. Journal of Ethnopharmacology 2005 98 1-2 177 183 2-s2.0-14844309721 10.1016/j.jep.2005.01. 026 (Pubitemid 40349184)
8. Qin Z., Den H., Zhuang H., Effect of oxymatrine on prolonging the survival time of cardiac tissue allograft in mice and its immunologic mechanisms. Chinese Journal of Integrated Traditional and Western Medicine 1990 10 2 99 100 2-s2.0-0025381992
9. Cui H. L., Wang Y. F., Li X. L., Kang Q. X., Clinical observation of matrine injection in the treatment of 51 cases of various types of cancers. Shanxi Medical Journal 1993 22 232 233
10. Bai H., Clinical observation of matrine injection in the treatment of middle and late stage cancers. Shenzhen Medical Journal 1996 9 33 34
11. Huang S., Li J., Zhu J. L., Hu X. L., Clinical observation on the efficacy of matrine injection in treating middle and late stage gastric cancer. Chinese Journal of Integrated Traditional and Western Medicine 1997 17, article 364
12. Mei Z. J., Hong Y. K., Zhao S. B., Hao D. Z., Hu S. M., Xie M. Y., Ge S. X., Liu C. Y., Zeng L. F., Su D. X., Zhu S. L., Hong, G Q., Clinical investigation of matrine Injection in treating late stage cancers. Huaxi Medical Journal 1993 8, article 334
13. Zhu J. L., Chen J. Z., Short-term observation on the efficacy of matrine injection in treating 79 cases of late stage cancers. Shandong Medical Journal 2003 43, article 40
14. Zhang Z. J., Effects of matrine Injection in treating 44 cases of primary carcinoma of the liver. Guangxi Traditional Medicine 1998 21 19 20
15. Bao L. Q., Peng A. M., Yuan H. Y., Clinic study on the role of hydroxycamptothecin and mateling postoperative arterial infusion in the prevention of recurrence after curative resection for human hepatocellular carcinoma. Research on Prevention and Treament of Tumor 2001 28 303 305
16. Zhu Y. J., Chen X. F., Huang Y. L., Clinical observation on the efficacy of mateling injection combined with abdominal chemotherapy in treating 21 cases of malignant ascites. Chinese Journal of Integrated Traditional and Western Medicine on Gastro-Spleen 2000 8 311 312
17. Zhou Y. F., Clinical observation on the efficacy of mateling injection combined with abdominal chemotherapy in treating malignant ascites. Journal of Emergency in Traditional Chinese Medicine 2004 13 286 287
18. Shi L. H., Qiu Y. H., Clinical investigation of kosam combined with chemotherapy to treat advanced malignant tumor. Journal of Tumor 2001 7 95 97
19. Chen Y. Z., Li Y. Q., Wang, Fufang Kushen Injection in treatment of mild or moderate cancer pain. Journal of Beijing University of Traditional Chinese Medicine 2012 35 61 69
20. Dou L. H., Guo Z., Efficacy observation of fentanyl skin patches combined with compound Sophora flavescens injection in the treatment of cancer pain. China Pharmacy 2012 23 1480 1482
21. Yuan C. J., Zhao W. Z., Wang J. K., Efficacy observation of chemotherapy with compound Sophora flavescens injection in the treatment of elderly patients with advanced gastric cancer. Shandong Medicine 2012 52 51 52
22. Feng B., Zhao X. Q., Effect of composite Radix Sophora Flavescentis injection on immunological function in patients with lung cancer. China Pharmacy 2007 18 2612 2613
23. Wang X. H., Li Y. H., Yang J. Q., Zhang R. J., Wang J. G., Hu W. N., Impact of compound matrine injection on clinical efficacy and immune functions among breast carcinoma patients undergoing postoperative chemotherapy. Chinese General Practice 2011 14 2696 2698
24. Wang Y. L., Fang H., Wang X. C., Zhou K. M., To observe the clinical effect of complex kushen injection with TACE on middle and advanced stages of primary hepatic carcinoma. Shangdong Medicine 2011 51 88 89
25. Shi Q., Wang Z. X., Zhao Q. H., Compound matrine injection combined with FOLFIRI chemotherapy in the treatment of 50 patients with advanced colorectal cancer. Chinese Journal of New Drugs 2010 19 1589 1592
26. Lu Z., Qi L., Li G. X., Ma C. G., Liu J., Liu K., Clinical efficiency of compound Kushen injection combined with radiotherapy in the treatment of patients with cervical cancer. China Journal of Hospital Pharmacy 2011 31 1114 1117
27. Li H. J., Liang Y. G., Zhang G. X., Effect of compound Sophora flavescens injection on attenuating the toxicity of chemotherapy for acute leukemia. China Pharmacy 2012 23 323 325
28. Zhang L., Compound matrine injection in the treatment of 32 patients with malignant pleural effusion. Journal of Traditional Chinese Medicine 2011 52 1149 1150
29. Guo X. D., Jiang T. H., Zhang W. W., Zhang X. M., Han K. Q., Clinical observation on kurorinone in preventing hepatic injury caused by chemotherapy. Chinese Pharmaceutical Association 2010 26 336 338
30. Tan H. B., Zhang J., Zhang J. W., Tretment of advanced gastric cancer with composed Kushen injection combined with FOLFOX4 adjuvant chemotherapy. Medical Journal of Wuhan University 2012 33 215 218
31. Huang Z. F., Liu J. B., Li H. Z., Huang C. J., Effect of combination of composite Sophorae injection and chemotherapy for treatment of 30 advanced gastric cancer patients. West China Medical Journal 2009 24 2883 2885
32. Wang Z. Y., Li G. S., Huang H. X., Clinical observation on treatment of 75 mid-late stage cancer patients with yanshu injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006 26 8 681 684 2-s2.0-38049003261
33. Hu M. J., Zeng H., Wu Y. L., Zhang Y. P., Zhang S., Qiao M. M., Fu H., Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chinese Journal of Digestive Diseases 2005 6 2 68 71 2-s2.0-21644475166 10.1111/j.1443-9573.2005.00201.x (Pubitemid 40936488)
34. Zhang S., Qi J., Sun L., Cheng B., Pan S., Zhou M., Sun X., Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Molecular Biology Reports 2009 36 4 791 799 2-s2.0-61449105025 10.1007/s11033-008-9247-y
35. Liu X. S., Jiang J., Molecular mechanism of matrine-induced apoptosis in leukemia K562 cells. American Journal of Chinese Medicine 2006 34 6 1095 1103 2-s2.0-33845545298 10.1142/S0192415X06004557 (Pubitemid 44921253)
36. Yu P., Liu Q., Liu K., Yagasaki K., Wu E., Zhang G., Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF- κ B signaling. Cytotechnology 2009 59 3 219 229 2-s2.0-70449534614 10.1007/s10616-009-9225-9
37. Zhang Y., Zhang H., Yu P., Liu Q., Liu K., Duan H., Luan G., Yagasaki K., Zhang G., Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 2009 59 3 191 200 2-s2.0-70449533764 10.1007/s10616-009-9211-2
38. Luo C., Zhu Y., Jiang T., Lu X., Zhang W., Jing Q., Li J., Pang L., Chen K., Qiu F., Yu X., Yang J., Huang J., Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology 2007 229 3 245 252 2-s2.0-33845586865 10.1016/j.tox.2006.10.020 (Pubitemid 44937494)
39. Zhang J. Q., Li Y. M., Liu T., He W. T., Chen Y. T., Chen X. H., Li X., Zhou W. C., Yi J. F., Ren Z. J., Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World Journal of Gastroenterology 2010 16 34 4281 4290 2-s2.0-77957557122 10.3748/wjg.v16.i34.4281
40. Chui C. H., Lau F. Y., Tang J. C., Kan K. L., Cheng G. Y., Wong R. S., Kok S. H., Lai P. B., Ho R., Gambari R., Chan A. S., Activities of fresh juice of Scutellaria barbata and warmed water extract of Radix Sophorae Tonkinensis on anti-proliferation and apoptosis of human cancer cell lines. International Journal of Molecular Medicine 2005 16 2 337 341 2-s2.0-27744476907
41. Wang Y., Peng C., Zhang G., Liu Y., Li H., Shan J., Study on invasion and metastasis related factors in differentiation of SMMC-7721 cells induced by matrine. Zhong Yao Cai 2003 26 8 566 569 2-s2.0-1542644824
42. Wu X. Z., A new classification system of anticancer drugsbased on cell biological mechanisms. Medical Hypotheses 2006 66 5 883 887 2-s2.0-32144434621 10.1016/j.mehy.2005.11.036 (Pubitemid 43207640)
43. Liu X. Y., Fang H., Yang Z. G., Wang X. Y., Ruan L. M., Fang D. R., Ding Y. G., Wang Y. N., Zhang Y., Jiang X. L., Chen H. C., Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. International Journal of Dermatology 2008 47 5 448 456 2-s2.0-42449159756 10.1111/j.1365-4632.2008.03627.x (Pubitemid 351560308)
44. Dai Z. J., Gao J., Wang X. J., Ji Z. Z., Wu W. Y., Liu X. X., Kang H. F., Guan H. T., Ren H. T., Apoptotic mechanism of gastric carcinoma cells induced by matrine injection. Zhonghua Wei Chang Wai Ke Za Zhi 2008 11 3 261 265 2-s2.0-77649277749
45. Han J., Sun M., Cui Y., Wang T., Zhang W., Guo M., Zhou Y., Liu W., Zhang M., Duan J., Xiong S., Yao M., Yan X., Kushen flavonoids induce apoptosis in tumor cells by inhibition of NF- κ B activation and multiple receptor tyrosine kinase activities. Phytotherapy Research 2007 21 3 262 268 2-s2.0-33947575828 10.1002/ptr.2065 (Pubitemid 46479678)
46. Sun M. Y., Zuo J., Duan J. F., Han J., Fan S. M., Zhang W., Zhu L. F., Yao M. H., Antitumor activities of kushen flavonoids in vivo and in vitro. Zhong Xi Yi Jie He Xue Bao 2008 6 1 51 59 2-s2.0-38649103528 10.3736/jcim20080111 (Pubitemid 351166466)
47. Son J. K., Park J. S., Kim J. A., Kim Y., Chung S. R., Lee S. H., Prenylated flavonoids from the roots of Sophora flavescens with tyrosinase inhibitory activity. Planta Medica 2003 69 6 559 561 2-s2.0-0037826011 10.1055/s-2003-40643 (Pubitemid 36870635)
48. Kim S. J., Son K. H., Chang H. W., Kang S. S., Kim H. P., Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens. Biological and Pharmaceutical Bulletin 2003 26 9 1348 1350 2-s2.0-2142754392 (Pubitemid 41656576)
49. Hyun S. K., Lee W. H., Jeong D. M., Kim Y., Choi J. S., Inhibitory effects of kurarinol, kuraridinol, and trifolirhizin from Sophora flavescens on tyrosinase and melanin synthesis. Biological and Pharmaceutical Bulletin 2008 31 1 154 158 2-s2.0-38049049927 10.1248/bpb.31.154
50. Ryu Y. B., Westwood I. M., Kang N. S., Kim H. Y., Kim J. H., Moon Y. H., Park K. H., Kurarinol, tyrosinase inhibitor isolated from the root of Sophora flavescens. Phytomedicine 2008 15 8 612 618 2-s2.0-46049085804 10.1016/j.phymed.2007.09.022 (Pubitemid 351899109)
51. vanden Berghe W., de Naeyer A., Dijsselbloem N., David J. P., de Keukeleire D., Haegeman G., Attenuation of ERK/RSK2-driven NF κ B gene expression and cancer cell proliferation by kurarinone, a lavandulyl flavanone isolated from Sophora flavescens Ait. roots. Endocrine, Metabolic and Immune Disorders 2011 11 3 247 261 2-s2.0-79961044176
52. Lai J. P., He X. W., Jiang Y., Chen F., Preparative separation and determination of matrine from the Chinese medicinal plant Sophora flavescens Ait by molecularly imprinted solid-phase extraction. Analytical and Bioanalytical Chemistry 2003 375 2 264 269 2-s2.0-0037264313 10.1007/s00216-002-1675-2 (Pubitemid 41201303)
53. Zhang L. P., Jiang J. K., Tam J. W. O., Zhang Y., Liu X. S., Xu X. R., Liu B. Z., He Y. J., Effects of matrine on proliferation and differentiation in K-562 cells. Leukemia Research 2001 25 9 793 800 2-s2.0-0034900502 10.1016/S0145-2126(00)00145-4 (Pubitemid 32734092)
54. Liu J. Y., Hu J. H., Zhu Q. G., Li F. Q., Wang J., Sun H. J., Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. International Immunopharmacology 2007 7 6 816 823 2-s2.0-34247376897 10.1016/j.intimp.2007.02. 003 (Pubitemid 46635279)
55. Zhang L., Wang T., Wen X., Wei Y., Peng X., Li H., Wei L., Effect of matrine on HeLa cell adhesion and migration. European Journal of Pharmacology 2007 563 13 69 76 2-s2.0-34247128303 10.1016/j.ejphar.2007.01.073 (Pubitemid 46602230)
56. Li Y., Wang B., Zhou C., Bi Y., Matrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: effects on Bcl-2/Bax expression and caspase-3 activation. Basic and Clinical Pharmacology and Toxicology 2007 101 1 1 8 2-s2.0-34250612339 10.1111/j.1742-7843.2006.00040.x (Pubitemid 46934645)
57. Zou J., Ran Z. H., Xu Q., Xiao S. D., Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116. Chinese Journal of Digestive Diseases 2005 6 1 15 20 2-s2.0-16344395310 10.1111/j.1443-9573.2005. 00181.x (Pubitemid 40467729)
58. Mao H. S., Liu H. Y., Li C., Modulation of the malignant phenotype and the immunological response of tumor cells by Sophora flavescens Ait (AF-7). Chinese Journal of Clinical Oncology 1996 23 11 799 803 2-s2.0-0029802466 (Pubitemid 26412862)
59. Li L. J., Chen Z. Q., Zheng Y. Y., Tang W. X., Yu Y., In vitro effects of oxymatrine on human ovarian cancer cell SKOV-3. Journal of Practical Oncology 2003 17 100 101
60. Ma L. T., Zhang Y., Wen S. H., He Y. J., Kang G. F., Jiang J. K., Experimental study of the antitumor effects of oxymatrine on murine H22 hepatoma. Academic Journal of Chongqing Medical University 2005 30 178 182
61. Wang Y., Si W. K., Li P., Yao J., Effects of matrine and oxymatrine on the proliferation and apoptosis of A549 cells. Academic Journal of Third Military Medical University 2004 26 778 780
62. Kong Q. Z., Huang T., Huang D. S., Feng G., Lu H. D., Fei Y., Feng J. P., Inhibitory effects of oxymatrine on angiogenesis of murine S180 sarcoma. China Pharmacist 2003 6 769 771
63. Xu G. W., Man S. J., Wang Z. S., Wang L. B., Effect of oxymatrine on immunology of tumor-bearing mice. Chinese Journal of Clinical Oncology and Rehabilitation 2001 8 9 10
64. Liu X. S., Jiang J., Jiao X. Y., Wu Y. E., Lin J. H., matrine-induced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways. Planta Medica 2006 72 6 501 506 2-s2.0-33744899623 10.1055/s-2006-931534 (Pubitemid 43844676)
65. Liu X. Y., Fang H., Yang Z. G., Wang X. Y., Ruan L. M., Fang D. R., Ding Y. G., Wang Y. N., Zhang Y., Jiang X. L., Chen H. C., Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. International Journal of Dermatology 2008 47 5 448 456 2-s2.0-42449159756 10.1111/j.1365-4632.2008.03627.x (Pubitemid 351560308)
66. Jiang H., Hou C., Zhang S., Xie H., Zhou W., Jin Q., Cheng X., Qian R., Zhang X., Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. European Journal of Pharmacology 2007 559 2-3 98 108 2-s2.0-33847136330 10.1016/j.ejphar.2006.12.017 (Pubitemid 46295409)
67. Zhang S., Qi J., Sun L., Cheng B., Pan S., Zhou M., Sun X., Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Molecular Biology Reports 2009 36 4 791 799 2-s2.0-61449105025 10.1007/s11033-008-9247-y
68. Yang L., Chen J. W., Lin Y. S., Clinical observation on the efficacy of mateling injection combined with radiotherapy in treating nasopharyngeal tumors. Strait Pharmaceutical Journal 1996 8 41 43
69. Hu M. J., Zeng H., Wu Y. L., Zhang Y. P., Zhang S., Qiao M. M., Fu H., Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chinese Journal of Digestive Diseases 2005 6 2 68 71 2-s2.0-21644475166 10.1111/j.1443-9573.2005.00201.x (Pubitemid 40936488)
70. Luo C., Zhu Y., Jiang T., Lu X., Zhang W., Jing Q., Li J., Pang L., Chen K., Qiu F., Yu X., Yang J., Huang J., Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology 2007 229 3 245 252 2-s2.0-33845586865 10.1016/j.tox.2006.10.020 (Pubitemid 44937494)
71. Ma L., Wen S., Zhan Y., He Y., Liu X., Jiang J., Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Medica 2008 74 3 245 251 2-s2.0-41349091860 10.1055/s-2008-1034304 (Pubitemid 351449946)
72. Zhang L., Wang T., Wen X., Wei Y., Peng X., Li H., Wei L., Effect of matrine on HeLa cell adhesion and migration. European Journal of Pharmacology 2007 563 13 69 76 2-s2.0-34247128303 10.1016/j.ejphar.2007.01.073 (Pubitemid 46602230)
73. Song M. Q., Zhu J. S., Chen J. L., Wang L., Da W., Zhu L., Zhang W. P., Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells. World Journal of Gastroenterology 2007 13 12 1788 1793 2-s2.0-34248215651 (Pubitemid 46706010)
74. Ling Q., Xu X., Wei X., Wang W., Zhou B., Wang B., Zheng S., Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. Journal of Experimental and Clinical Cancer Research 2011 30 1, article 66 2-s2.0-79959641621 10.1186/1756-9966-30-66
75. Zhang Y., Piao B., Zhang Y., Hua B., Hou W., Xu W., Qi X., Zhu X., Pei Y., Lin H., Oxymatrine diminishes the side population and inhibits the expression of β -catenin in MCF-7 breast cancer cells. Medical Oncology 2011 28 supplement 1 99 107 2-s2.0-78049517499 10.1007/s12032-010-9721-y
76. Hong Y. G., Huang T., Wang J. S., Effect of Compound kushen injection combined with chemotherapy on immune function and CEA in advanced lung adenocarcinoma. Chinese Journal of New Drugs 2012 21 14 1633 1635
77. Chen J., Mei Q., Xu Y. C., Du J., Wei Y., Xu Z. M., Effects of matrine Injection on T-lymphocyte subsets of patients with malignant tumor after gamma knife radiosurgery. Zhong Xi Yi Jie He Xue Bao 2006 4 1 78 79 2-s2.0-33746541214 10.3736/jcim20060121
78. Dai Z. J., Gao J., Wu W. Y., Wang X. J., Li Z. F., Kang H. F., Liu X. X., Ma X. B., Effect of matrine injections on invasion and metastasis of gastric carcinoma SGC-7901 cells in vitro. Zhong Yao Cai 2007 30 7 815 819 2-s2.0-41349117691
79. Kuroyanagi M., Arakawa T., Hirayama Y., Hayashi T., Antibacterial and antiandrogen flavonoids from Sophora flavescens. Journal of Natural Products 1999 62 12 1595 1599 2-s2.0-0033451463 10.1021/np990051d (Pubitemid 30030595)
80. Woo E. R., Kwak J. H., Kim H. J., Park H., A new prenylated flavonol from the roots of Sophora flavescens. Journal of Natural Products 1998 61 12 1552 1554 2-s2.0-0032423245 10.1021/np980103j (Pubitemid 29024438)
81. Ryu S. Y., Choi S. U., Kim S. K., No Z., Lee C. O., Ahn J. W., In vitro antitumour activity of flavonoids from Sophora flavescens. Phytotherapy Research 1997 11 1 51 53 (Pubitemid 27094803)
82. Kang T. H., Jeong S. J., Ko W. G., Kim N. Y., Lee B. H., Inagaki M., Miyamoto T., Higuchi R., Kim Y. C., Cytotoxic lavandulyl flavanones from Sophora flavescens. Journal of Natural Products 2000 63 5 680 681 2-s2.0-0034115008 10.1021/np990567x (Pubitemid 30395531)
83. Zhao Y. Y., Zhang R. Y., Research on chemical constituents of Sophora flavescens. Natural Product Research And Development 1991 3 93 103
84. Ding P., Chen D., Bastow K. F., Nyarko A. K., Wang X., Lee K. H., Cytotoxic isoprenylated flavonoids from the roots of Sophora flavescens. Helvetica Chimica Acta 2004 87 10 2574 2580 2-s2.0-8644278708 10.1002/hlca.200490230 (Pubitemid 39506771)
85. Han J. M., Jin Y. Y., Kim H. Y., Park K. H., Lee W. S., Jeong T. S., Lavandulyl flavonoids from Sophora flavescens suppress lipopolysaccharide- induced activation of nuclear factor- κ B and mitogen-activated protein kinases in RAW264.7 cells. Biological and Pharmaceutical Bulletin 2010 33 6 1019 1023 2-s2.0-77953434456 10.1248/bpb.33.1019